IFP Advisors
IRWD icon

IFP Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

IFP Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.02K Sell
2,019
-297
-13% -$1.24K ﹤0.01% 3541
2026
Q2 		$9.8K Sell
2,316
-1,717
-43% -$6.62K ﹤0.01% 3409
2026
Q1 		$14.2K Hold
4,033
– – ﹤0.01% 2974
2025
Q4 		$13.6K Buy
4,033
+8
+0.2% +$21 ﹤0.01% 2914
2025
Q3 		$5.27K Buy
4,025
+619
+18% +$641 ﹤0.01% 3217
2025
Q2 		$2.44K Buy
3,406
+2,979
+698% +$2.34K ﹤0.01% 3805
2025
Q1 		$628 Sell
427
-7
-2% -$17 ﹤0.01% 3417
2024
Q4 		$1.92K Buy
+434
New +$1.76K ﹤0.01% 3116
2024
Q3 		– Sell
-144
Closed -$939 – 3377
2024
Q2 		$939 Buy
+144
New +$1.02K ﹤0.01% 3001
2023
Q4 		– Sell
-455
Closed -$4.38K – 3201
2023
Q3 		$4.38K Buy
+455
New +$4.46K ﹤0.01% 2559
2023
Q1 		– Sell
-2,013
Closed -$38K – 3917
2022
Q4 		$38K Buy
2,013
+8
+0.4% +$91 ﹤0.01% 2425
2022
Q3 		$38K Sell
2,005
-21
-1% -$238 ﹤0.01% 2583
2022
Q2 		$38K Hold
2,026
– – ﹤0.01% 2349
2022
Q1 		$38K Buy
+2,026
New +$23.2K ﹤0.01% 2349
2020
Q4 		– Sell
-140
Closed -$1.53K – 3018
2020
Q3 		$1K Hold
140
– – ﹤0.01% 2648
2020
Q2 		$1K Hold
140
– – ﹤0.01% 2551
2020
Q1 		$1K Buy
+140
New +$1.65K ﹤0.01% 2550
2018
Q4 		– Sell
-59
Closed -$1K – 3704
2018
Q3 		$1K Sell
59
-14
-19% -$221 ﹤0.01% 3692
2018
Q2 		$1K Buy
+73
New +$1.08K ﹤0.01% 3734
2017
Q3 		– Sell
-79
Closed -$1K – 4132
2017
Q2 		$1K Buy
+79
New +$1.15K ﹤0.01% 3896

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

IFP Advisors's IRWD Position: Q3 2026 in Review

IFP Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 13% in Q3 2026, selling an estimated $1.24K and leaving 2,019 shares worth $8.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

IFP Advisors first reported a position in IRWD in Q2 2017 and has held it in 20 quarters since. The position peaked at $38K in Q4 2022. 21 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • IFP Advisors held 2,019 shares of Ironwood Pharmaceuticals worth $8.02K as of Q3 2026.
  • IFP Advisors sold 297 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.24K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3541 holding.
  • IFP Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and has held it in 20 quarters since.
  • IFP Advisors's Ironwood Pharmaceuticals position peaked at $38K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.